Novartis drug causes two children to die of liver failure from gene therapy drug
Novartis Pharmaceuticals is reporting that two children have died after taking Zolgensma, a gene therapy drug designed to treat a rare condition called spinal muscular atrophy. In an email statement, Novartis says the children died from acute liver failure about six weeks after receiving an infusion of Zolgensma, and one to 10 days after tapered […]
Continue reading Novartis drug causes two children to die of liver failure from gene therapy drug on sharylattkisson.com.
